Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Biosortia Pharmaceuticals

Biosortia Pharmaceuticals

Biosortia is a therapeutics, agrochemical and cosmetics company developing products from microbial small molecules through microbiome mining.

Biosortia is a therapeutics, agrochemical and cosmetics company developing products from microbial small molecules through microbiome mining. Biosortia establishes libraries of natural molecule activity and derivatives from microorganisms extracted from the natural world. Biosortia is in the JLABS incubator and received a $1 million annual recurring revenue (ARR) contract with the Department of Homeland Security.

As part of their cancer drug discovery research Biosortia tests compounds isolated from microorganisms on cancer cell lines. Biosortia sampled from cyanobacterial blooms in Buckeye Lake and Grand Lake St. Marys in Ohio and disovered a new series of cardiotoxic steroids. The group also discovered new cytotoxic compounds from a Microcystis aeruginosa bloom.

Timeline

October 28, 2018
Cyanobufalins: Cardioactive Toxins from Cyanobacterial Blooms
May 30, 2018
Microcystins Containing Doubly Homologated Tyrosine Residues from a Microcystis aeruginosa Bloom: Structures and Cytotoxicity
August 14, 2017
Leidos and Biosortia Pharmaceuticals Execute Memorandum of Understanding

MOU to explore a new business relationship focused on leveraging assets and drug discovery capabilities for immuno-oncology application

Patents

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

The Donna Drake Show Live It Up with Ross O Youngs on Biosortia Pharmaceutical

References

Golden logo
By using this site, you agree to our Terms & Conditions.